Pharmaceutical composition for treating spinocerebellar ataxia

Details Pharmaceutical composition for treating spinocerebellar ataxia Pharmaceutical composition for treating spinocerebellar ataxia

2005-09-08

2011-12-06

Wang, Shengjun (Department: 1627)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S017700, C514S018200, C514S021900

Reexamination Certificate

active

08071633

ABSTRACT:
This invention provide to a pharmaceutical composition for treating spinocerebellar ataxia (or atrophy, degeneration) or multiple system atrophy, or for improving ataxia or equilibrium disturbance comprising a compound of the formula (I):wherein R is methyl, cyano or carbamoyl, a pharmaceutically acceptable salt, or a solvate thereof as an active ingredient.

REFERENCES:
patent: 5151497 (1992-09-01), Uchida et al.
patent: 5686420 (1997-11-01), Faden
patent: 6319902 (2001-11-01), Sugawara et al.
patent: 7129256 (2006-10-01), Shinohaea et al.
patent: 0 933 379 (1999-08-01), None
patent: 0 384 380 (1990-08-01), None
patent: 1084704 (2001-03-01), None
patent: 1300155 (2003-04-01), None
patent: 1 321 151 (2003-06-01), None
patent: 59-155346 (1984-09-01), None
patent: 60-190795 (1985-09-01), None
patent: 61-033197 (1986-02-01), None
patent: 63-290876 (1988-11-01), None
patent: 09-157286 (1997-06-01), None
patent: WO-99/53941 (1999-10-01), None
Kinoshita et al. “Taltirelin Hydrate (TA-0910): An orally active thyrotropin-releasing hormone mimetic agent with multiple actions,” CNS Drug Reviews, 1998, vol. 4, No. 1, pp. 25-41.
The Merck Munal, Fifteenth Edition, 1987, pp. 1421-1423.
Miyamoto et al., “Effects of a sustained release formulation of thyrotropin-releasing hormone on behavioral abnormalities in senescence-accelerated mice”, European Journal of Pharmacology, vol. 271, pp. 357-366, 1994.
Asu no Shinyaku 2004, 409.
Nanzando's Medical Dictionary (1990.2.1, Ver. 17, pp. 235, 1085, and 1122).

Affiliated with

Also associated with

Rating

Pharmaceutical composition for treating spinocerebellar ataxia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for treating spinocerebellar ataxia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for treating spinocerebellar ataxia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4312014